Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1998-12-16
pubmed:abstractText
Although the efficacy of isotretinoin in the treatment of acne is unquestioned, improvement of patient tolerance and acceptance of the drug are desirable. Furthermore, no data on acne-induced scarring during isotretinoin treatment are available.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0926-9959
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
117-21
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:9784036-Acne Vulgaris, pubmed-meshheading:9784036-Adolescent, pubmed-meshheading:9784036-Adult, pubmed-meshheading:9784036-Child, pubmed-meshheading:9784036-Dose-Response Relationship, Drug, pubmed-meshheading:9784036-Facial Dermatoses, pubmed-meshheading:9784036-Female, pubmed-meshheading:9784036-Follow-Up Studies, pubmed-meshheading:9784036-Humans, pubmed-meshheading:9784036-Isotretinoin, pubmed-meshheading:9784036-Keratolytic Agents, pubmed-meshheading:9784036-Lipids, pubmed-meshheading:9784036-Male, pubmed-meshheading:9784036-Middle Aged, pubmed-meshheading:9784036-Musculoskeletal Diseases, pubmed-meshheading:9784036-Pain, pubmed-meshheading:9784036-Patient Compliance, pubmed-meshheading:9784036-Patient Satisfaction, pubmed-meshheading:9784036-Recurrence, pubmed-meshheading:9784036-Skin, pubmed-meshheading:9784036-Treatment Outcome
pubmed:year
1998
pubmed:articleTitle
Medium dose isotretinoin for the treatment of acne.
pubmed:affiliation
Department of Dermatology, Charité-Virchow Clinic, Humboldt University, Berlin, Germany.
pubmed:publicationType
Journal Article, Clinical Trial